Literature DB >> 9176231

Interleukin-15 signals T84 colonic epithelial cells in the absence of the interleukin-2 receptor beta-chain.

A C Stevens1, J Matthews, P Andres, V Baffis, X X Zheng, D W Chae, J Smith, T B Strom, W Maslinski.   

Abstract

Interleukin-15 (IL-15) shares many biological functions with interleukin-2 (IL-2) due to common receptor components. IL-15 binds to the IL-2 receptor (IL-2R) beta-chain and the common gamma-chain receptor in addition to one other IL-15 binding receptor protein (IL-15R alpha). Both IL-2R beta- and gamma-chains are required to promote cell growth in hematopoietic cells. The colonic cryptlike epithelial cell line T84 contains the common gamma-chain but lacks the IL-2R beta-chain. We report IL-15R alpha-chain mRNA in T84 cells with the use of reverse transcriptase-polymerase chain reaction. T84 and normal colonic epithelial cells bind a FLAG-IL-15 fusion protein in immunoperoxidase and flow cytometric experiments. In addition, IL-15, but not IL-2, accelerates and enhances the development of transepithelial resistance across T84 monolayers in a dose-dependent fashion. We conclude that normal and T84 colonic epithelial cells express IL-15R alpha and are able to bind IL-15. IL-15 can deliver a nonproliferative functional signal in the absence of IL-2R beta-chain in T84 cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176231     DOI: 10.1152/ajpgi.1997.272.5.G1201

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Interleukin-15 strongly inhibits interleukin-8 and monocyte chemoattractant protein-1 production in human colonic epithelial cells.

Authors:  N Lügering; T Kucharzik; C Maaser; M Kraft; W Domschke
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity.

Authors:  Y S Kim; W Maslinski; X X Zheng; A C Stevens; X C Li; G H Tesch; V R Kelley; T B Strom
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

Review 3.  The intestinal epithelial cell: immunological aspects.

Authors:  A D Christ; R S Blumberg
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Smooth muscle homeostasis in human atherosclerotic plaques through interleukin 15 signalling.

Authors:  Jelger J van der Meer; Onno J de Boer; Peter Teeling; Chris M van der Loos; Mark C Dessing; Allard C van der Wal
Journal:  Int J Clin Exp Pathol       Date:  2011-03-22

Review 5.  Functions of IL-15 in anti-viral immunity: multiplicity and variety.

Authors:  Katherine C Verbist; Kimberly D Klonowski
Journal:  Cytokine       Date:  2012-06-15       Impact factor: 3.861

Review 6.  IL-2 and Beyond in Cancer Immunotherapy.

Authors:  John M Wrangle; Alicia Patterson; C Bryce Johnson; Daniel J Neitzke; Shikhar Mehrotra; Chadrick E Denlinger; Chrystal M Paulos; Zihai Li; David J Cole; Mark P Rubinstein
Journal:  J Interferon Cytokine Res       Date:  2018-02       Impact factor: 2.607

7.  Establishment of an in vitro brain barrier epithelial transport system for pharmacological and toxicological study.

Authors:  Lewis Zhichang Shi; Wei Zheng
Journal:  Brain Res       Date:  2005-09-28       Impact factor: 3.252

8.  Interleukin 2 modulates ion secretion and cell proliferation in cultured human small intestinal enterocytes.

Authors:  E V O'Loughlin; G P Pang; R Noltorp; C Koina; R Batey; R Clancy
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

9.  Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.

Authors:  Jing Wei; Chen Guo; Xiang An; Wenxuan Miao; Chenli Zhang; Binsheng Wang; Wei Cai; Min Li; Fangfang Zhang
Journal:  Cell Oncol (Dordr)       Date:  2020-08-07       Impact factor: 6.730

10.  Simultaneous profiling of 194 distinct receptor transcripts in human cells.

Authors:  Byong H Kang; Karin J Jensen; Jaime A Hatch; Kevin A Janes
Journal:  Sci Signal       Date:  2013-08-06       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.